595 related articles for article (PubMed ID: 32828637)
41. Untargeted metabolomic analysis of urine samples in the diagnosis of some inherited metabolic disorders.
Janeckova H; Kalivodova A; Najdekr L; Friedecky D; Hron K; Bruheim P; Adam T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):582-5. PubMed ID: 25482736
[TBL] [Abstract][Full Text] [Related]
42. Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism.
Kennedy AD; Miller MJ; Beebe K; Wulff JE; Evans AM; Miller LA; Sutton VR; Sun Q; Elsea SH
Genet Test Mol Biomarkers; 2016 Sep; 20(9):485-95. PubMed ID: 27448163
[TBL] [Abstract][Full Text] [Related]
43. Transaldolase deficiency in two new patients with a relative mild phenotype.
Tylki-Szymańska A; Stradomska TJ; Wamelink MM; Salomons GS; Taybert J; Pawłowska J; Jakobs C
Mol Genet Metab; 2009 May; 97(1):15-7. PubMed ID: 19299175
[TBL] [Abstract][Full Text] [Related]
44. The role of the Human Metabolome Database in inborn errors of metabolism.
Mandal R; Chamot D; Wishart DS
J Inherit Metab Dis; 2018 May; 41(3):329-336. PubMed ID: 29663269
[TBL] [Abstract][Full Text] [Related]
45. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
[TBL] [Abstract][Full Text] [Related]
46. Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides.
Li M; Lu Y; Li Y; Tong L; Gu XC; Meng J; Zhu Y; Wu L; Feng M; Tian N; Zhang P; Xu T; Lin SH; Tong X
Cancer Res; 2019 Jul; 79(14):3689-3701. PubMed ID: 31101762
[No Abstract] [Full Text] [Related]
47. Untargeted Metabolomics for Metabolic Diagnostic Screening with Automated Data Interpretation Using a Knowledge-Based Algorithm.
Haijes HA; van der Ham M; Prinsen HCMT; Broeks MH; van Hasselt PM; de Sain-van der Velden MGM; Verhoeven-Duif NM; Jans JJM
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024143
[TBL] [Abstract][Full Text] [Related]
48. Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
You X; Jiang W; Lu W; Zhang H; Yu T; Tian J; Wen S; Garcia-Manero G; Huang P; Hu Y
Cancer Commun (Lond); 2019 Apr; 39(1):17. PubMed ID: 30947742
[TBL] [Abstract][Full Text] [Related]
49. Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.
Qian Y; Banerjee S; Grossman CE; Amidon W; Nagy G; Barcza M; Niland B; Karp DR; Middleton FA; Banki K; Perl A
Biochem J; 2008 Oct; 415(1):123-34. PubMed ID: 18498245
[TBL] [Abstract][Full Text] [Related]
50. Clinical metabolomics for inborn errors of metabolism.
Ford L; Mitchell M; Wulff J; Evans A; Kennedy A; Elsea S; Wittmann B; Toal D
Adv Clin Chem; 2022; 107():79-138. PubMed ID: 35337606
[TBL] [Abstract][Full Text] [Related]
51. Untargeted Metabolomics-Based Screening Method for Inborn Errors of Metabolism using Semi-Automatic Sample Preparation with an UHPLC- Orbitrap-MS Platform.
Bonte R; Bongaerts M; Demirdas S; Langendonk JG; Huidekoper HH; Williams M; Onkenhout W; Jacobs EH; Blom HJ; Ruijter GJG
Metabolites; 2019 Nov; 9(12):. PubMed ID: 31779119
[TBL] [Abstract][Full Text] [Related]
52. A compendium of inborn errors of metabolism mapped onto the human metabolic network.
Sahoo S; Franzson L; Jonsson JJ; Thiele I
Mol Biosyst; 2012 Oct; 8(10):2545-58. PubMed ID: 22699794
[TBL] [Abstract][Full Text] [Related]
53. Ex vivo proton spectroscopy (
Cannet C; Frauendienst-Egger G; Freisinger P; Götz H; Götz M; Himmelreich N; Kock V; Spraul M; Bus C; Biskup S; Trefz F
NMR Biomed; 2023 Apr; 36(4):e4853. PubMed ID: 36264537
[TBL] [Abstract][Full Text] [Related]
54. Clinical diagnosis of metabolic disorders using untargeted metabolomic profiling and disease-specific networks learned from profiling data.
Thistlethwaite LR; Li X; Burrage LC; Riehle K; Hacia JG; Braverman N; Wangler MF; Miller MJ; Elsea SH; Milosavljevic A
Sci Rep; 2022 Apr; 12(1):6556. PubMed ID: 35449147
[TBL] [Abstract][Full Text] [Related]
55. Study of transaldolase deficiency in urine samples by capillary LC-MS/MS.
Vas G; Conkrite K; Amidon W; Qian Y; Bánki K; Perl A
J Mass Spectrom; 2006 Apr; 41(4):463-9. PubMed ID: 16470722
[TBL] [Abstract][Full Text] [Related]
56. [A newly discovered metabolic diseases due to defects in the pentose pathway].
Tylki-Szymańska A; Stradomska TJ
Postepy Biochem; 2011; 57(2):168-71. PubMed ID: 21913417
[TBL] [Abstract][Full Text] [Related]
57. Targeted urine metabolomics with a graphical reporting tool for rapid diagnosis of inborn errors of metabolism.
Steinbusch LKM; Wang P; Waterval HWAH; Stassen FAPM; Coene KLM; Engelke UFH; Habets DDJ; Bierau J; Körver-Keularts IMLW
J Inherit Metab Dis; 2021 Sep; 44(5):1113-1123. PubMed ID: 33843072
[TBL] [Abstract][Full Text] [Related]
58. Transketolase in human Müller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways.
Chen Y; Zhang T; Zeng S; Xu R; Jin K; Coorey NJ; Wang Y; Wang K; Lee SR; Yam M; Zhu M; Chang A; Fan X; Zhang M; Du J; Gillies MC; Zhu L
Redox Biol; 2022 Aug; 54():102379. PubMed ID: 35779441
[TBL] [Abstract][Full Text] [Related]
59. Exchange reactions catalyzed by group-transferring enzymes oppose the quantitation and the unravelling of the identify of the pentose pathway.
Flanigan I; Collins JG; Arora KK; MacLeod JK; Williams JF
Eur J Biochem; 1993 Apr; 213(1):477-85. PubMed ID: 8477719
[TBL] [Abstract][Full Text] [Related]
60. Clinical Validation of Targeted and Untargeted Metabolomics Testing for Genetic Disorders: A 3 Year Comparative Study.
Almontashiri NAM; Zha L; Young K; Law T; Kellogg MD; Bodamer OA; Peake RWA
Sci Rep; 2020 Jun; 10(1):9382. PubMed ID: 32523032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
